Atlas Trials

An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis

Clinical trial NCT02646657 · COMPLETED

Trial details

NCT number
NCT02646657
Sponsor
Geert D'Haens
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Colitis, Ulcerative
Start date
2015-07-01
Primary completion
2020-08-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.